Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1

All possible direct-acting antiviral agent (DAA) regimens for treatment-naive hepatitis C genotype 1 were evaluated by many randomized controlled trials (RCTs). However, the optimum regimen remains inconclusive. We aim to compare interventions in terms of sustained virological response at 12 (SVR12)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Gui-Qi, Zou, Zhuo-Lin, Zheng, Ji-Na, Chen, Da-Zhi, Zou, Tian-Tian, Shi, Ke-Qing, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782908/
https://www.ncbi.nlm.nih.gov/pubmed/26945424
http://dx.doi.org/10.1097/MD.0000000000003004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782908/
https://www.ncbi.nlm.nih.gov/pubmed/26945424
http://dx.doi.org/10.1097/MD.0000000000003004

Ejemplares similares